ASTH Stock Overview
Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 3/6 |
Past Performance | 5/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for ASTH from our risk checks.
Astrana Health, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$52.20 |
52 Week High | US$54.27 |
52 Week Low | US$28.87 |
Beta | 1.16 |
11 Month Change | 30.40% |
3 Month Change | 42.16% |
1 Year Change | 50.17% |
33 Year Change | -40.93% |
5 Year Change | 251.28% |
Change since IPO | 381.55% |
Recent News & Updates
Is There Now An Opportunity In Astrana Health, Inc. (NASDAQ:ASTH)?
Jun 19Capital Allocation Trends At Astrana Health (NASDAQ:ASTH) Aren't Ideal
Jun 02Recent updates
Is There Now An Opportunity In Astrana Health, Inc. (NASDAQ:ASTH)?
Jun 19Capital Allocation Trends At Astrana Health (NASDAQ:ASTH) Aren't Ideal
Jun 02Astrana Health, Inc. (NASDAQ:ASTH) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
May 09Investors Still Waiting For A Pull Back In Astrana Health, Inc. (NASDAQ:ASTH)
Apr 15At US$40.82, Is Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Worth Looking At Closely?
Feb 25Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?
Feb 07Apollo Medical Holdings: Good Company, Not Quite A Hold
Jan 17With Apollo Medical Holdings, Inc. (NASDAQ:AMEH) It Looks Like You'll Get What You Pay For
Dec 27Returns On Capital At Apollo Medical Holdings (NASDAQ:AMEH) Have Stalled
Nov 08Should You Investigate Apollo Medical Holdings, Inc. (NASDAQ:AMEH) At US$30.62?
Oct 26Apollo Medical Holdings (NASDAQ:AMEH) Has A Pretty Healthy Balance Sheet
Sep 22Returns At Apollo Medical Holdings (NASDAQ:AMEH) Appear To Be Weighed Down
Aug 04A Look At The Intrinsic Value Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH)
Jul 19We Think Apollo Medical Holdings (NASDAQ:AMEH) Can Stay On Top Of Its Debt
Jun 19Apollo Medical Holdings' (NASDAQ:AMEH) Returns On Capital Are Heading Higher
May 05Does This Valuation Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Imply Investors Are Overpaying?
Apr 20Is Apollo Medical Holdings (NASDAQ:AMEH) A Risky Investment?
Mar 21Apollo Medical Holdings (NASDAQ:AMEH) Has More To Do To Multiply In Value Going Forward
Jan 06Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?
Dec 16Apollo Medical to acquire Valley Oaks Medical Group
Oct 05Apollo Medical to acquire a San Francisco Bay area physicians' group, health plan
Sep 26A Look At The Fair Value Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH)
Sep 21The Return Trends At Apollo Medical Holdings (NASDAQ:AMEH) Look Promising
Sep 06With EPS Growth And More, Apollo Medical Holdings (NASDAQ:AMEH) Makes An Interesting Case
Aug 22Apollo Medical Q2 GAAP EPS beats estimate, co reiterates FY 2022 revenue guidance
Aug 04Is Apollo Medical Holdings (NASDAQ:AMEH) A Risky Investment?
Aug 04Apollo Medical Holdings' (NASDAQ:AMEH) Returns On Capital Are Heading Higher
May 17We Think Apollo Medical Holdings (NASDAQ:AMEH) Can Manage Its Debt With Ease
May 02Shareholder Returns
ASTH | US Healthcare | US Market | |
---|---|---|---|
7D | 5.8% | 2.8% | -0.6% |
1Y | 50.2% | 8.3% | 17.3% |
Return vs Industry: ASTH exceeded the US Healthcare industry which returned 5.7% over the past year.
Return vs Market: ASTH exceeded the US Market which returned 17.5% over the past year.
Price Volatility
ASTH volatility | |
---|---|
ASTH Average Weekly Movement | 7.2% |
Healthcare Industry Average Movement | 7.0% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 14.7% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: ASTH's share price has been volatile over the past 3 months.
Volatility Over Time: ASTH's weekly volatility (7%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1985 | 1,800 | Brandon Sim | www.astranahealth.com |
Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.
Astrana Health, Inc. Fundamentals Summary
ASTH fundamental statistics | |
---|---|
Market cap | US$2.38b |
Earnings (TTM) | US$62.42m |
Revenue (TTM) | US$1.45b |
38.0x
P/E Ratio1.6x
P/S RatioIs ASTH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ASTH income statement (TTM) | |
---|---|
Revenue | US$1.45b |
Cost of Revenue | US$1.21b |
Gross Profit | US$241.07m |
Other Expenses | US$178.65m |
Earnings | US$62.42m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 07, 2024
Earnings per share (EPS) | 1.37 |
Gross Margin | 16.58% |
Net Profit Margin | 4.29% |
Debt/Equity Ratio | 86.0% |
How did ASTH perform over the long term?
See historical performance and comparison